Why Microencapsulation Is Transforming Micronutrient Premix Stability

One of the most persistent challenges in food and feed fortification is getting micronutrients to survive the journey from manufacturer to end consumer intact. High-temperature processing, moisture exposure, oxygen, and interactions between vitamins and minerals all degrade bioavailability before the product ever reaches a plate.

Microencapsulation — the process of coating individual nutrient particles in a protective shell — has become one of the most effective responses to this problem. At NutraX Biotech, it is central to how we approach formulation for both human nutrition and animal feed premixes.

What the shell actually does

The encapsulant creates a physical barrier between the active nutrient and its environment. Depending on the shell material — hydrogenated fats, modified starch, gelatin, maltodextrin — that barrier can protect against:

• Oxidation (particularly critical for vitamins A, D, E, and C)
• Moisture-induced clumping and degradation
• Off-flavours caused by vitamin-mineral interaction (iron with vitamin C is a well-documented example)
• Colour bleed that makes fortified food visually unacceptable to consumers
• Heat loss during extrusion, spray-drying, and pelleting in feed manufacturing

Not all encapsulation is equal

Shell thickness, shell material, and the encapsulation method itself (spray-drying vs. fluid-bed coating vs. spray-chilling) produce meaningfully different outcomes for the same nutrient. A fat-coated iron product designed for feed pelleting at 85°C will perform very differently from one intended for ambient-temperature wet mixes.

This is why buyers should ask suppliers for third-party stability data under their specific processing conditions — not generic shelf-life claims under idealised storage.

The business case for buying encapsulated forms

Encapsulated forms cost more per kilogram than standard forms of the same nutrient. The relevant question is not whether the encapsulated form is more expensive — it is whether the declared fortification level is actually achieved in the finished product, and whether regulatory claims are defensible under audit.

For regulated programmes — school feeding, therapeutic foods, fortified staples — this is not optional. For commercial FMCG fortification where health claims appear on pack, the answer is the same.

The cost of a recall or a failed assay at port-of-entry is orders of magnitude higher than the cost difference between standard and encapsulated inputs.

Stability is not a feature to negotiate out of a premix specification. It is the baseline from which everything else follows.

If you are formulating or sourcing a premix for a product that undergoes any heat processing, or that will sit on shelf for more than 12 months, the conversation with your supplier should begin with encapsulation — not end with it.